We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




License Deal for GPCR Drug Discovery

By Biotechdaily staff writers
Posted on 11 Jul 2002
A nonexclusive license to proprietary technology for drug discovery has been granted by the developer, Norak Biosciences (Research Triangle Park, NC, USA), to AstraZeneca (London, UK).

AstraZeneca will use the technology, Transfluor, for an internal G protein-coupled receptor (GPCR) drug discovery project. More...
AstraZeneca is to provide feedback to Norak on the performance and results of Transfluor use in high throughput screening against a large compound library. Norak will provide ongoing technology support and know-how related to GPCR targets. GPCRs are cell surface targets to which drugs bind to cause changes in intracellular function and are the richest receptor targets for drug discovery.

"The evaluation of the Transfluor technology to date has demonstrated the potential for this assay to contribute to AstraZeneca's drug discovery program,” said Elaine Sullivan, Ph.D., director of The Advanced Science and Technology Laboratory, AstraZeneca.

The patented Transfluor technology is designed to be the most accurate method for discovering ligands for GPCR targets, whether known or orphan. Norak is offering limited access to its Transfluor technology to the pharmaceutical industry via licensing and collaborations and is also conducting internal research to discover drugs for its own pipeline.




Related Links:
Norak

New
Gold Member
Automatic Hematology Analyzer
CF9600
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
New
Clinical Informatics Platform
CLARION™
New
HPV Test
Allplex HPV28 Detection
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Study results show blood protein levels change markedly in childhood and adolescence, with sex differences increasing with age (photo credit: Adobe Stock)

Proteomic Data Underscore Need for Age-Specific Pediatric Reference Ranges

Serum proteins underpin many routine tests used to detect inflammation, hormonal imbalance, cardiovascular disease, and metabolic disorders. Yet pediatric interpretation often relies on adult reference... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.